MARKET

PHVS

PHVS

Pharvaris N.V.
NASDAQ
34.84
-0.07
-0.20%
After Hours: 34.84 0 0.00% 19:34 08/10 EDT
OPEN
35.00
PREV CLOSE
34.91
HIGH
35.67
LOW
34.09
VOLUME
982.00K
TURNOVER
--
52 WEEK HIGH
36.60
52 WEEK LOW
19.56
MARKET CAP
2.41B
P/E (TTM)
-10.9937
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PHVS last week (0803-0807)?
Weekly Report · 15h ago
Can Pharvaris (PHVS) Turn AAE-C1INH Patient Insights Into a Lasting Clinical Advantage?
Simply Wall St · 1d ago
Pharvaris: One Molecule Could Reshape Both Sides Of HAE Treatment
Seeking Alpha · 6d ago
Morgan Stanley Sticks to Its Buy Rating for Pharvaris (PHVS)
TipRanks · 08/03 12:45
Weekly Report: what happened at PHVS last week (0727-0731)?
Weekly Report · 08/03 09:03
Weekly Report: what happened at PHVS last week (0720-0724)?
Weekly Report · 07/27 09:03
After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?
The Motley Fool · 07/24 11:21
Pharvaris announces publication of review article on bradykinin
TipRanks · 07/22 10:55
More
About PHVS
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.

Webull offers Pharvaris NV stock information, including NASDAQ: PHVS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PHVS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PHVS stock methods without spending real money on the virtual paper trading platform.